The Role of Microbiota-Related Co-Metabolites in MASLD Progression: A Narrative Review
Current Issues in Molecular Biology · 25.06.2024 · 46 (7) · 6377-6389
DOI: 10.3390/cimb46070381 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Current Issues in Molecular Biology, online erschienen am 25.06.2024. Verfasst von Maria Martin-Grau und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, University of Valencia, 46010 Valencia, Spain. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Valencia.
Abstract (Originalsprache)
Metabolic dysfunction-associated steatotic liver disease (MASLD) represents a growing health concern due to its increasing prevalence worldwide. Metabolic homeostasis encompasses the stable internal conditions vital for efficient metabolism. This equilibrium extends to the intestinal microbiota, whose metabolic activities profoundly influence overall metabolic balance and organ health. The metabolites derived from the gut microbiota metabolism can be defined as microbiota-related co-metabolites. They serve as mediators between the gut microbiota and the host, influencing various physiological processes. The recent redefinition of the term MASLD has highlighted the metabolic dysfunction that characterize the disease. Metabolic dysfunction encompasses a spectrum of abnormalities, including impaired glucose regulation, dyslipidemia, mitochondrial dysfunction, inflammation, and accumulation of toxic byproducts. In addition, MASLD progression has been linked to dysregulation in the gut microbiota and associated co-metabolites. Short-chain fatty acids (SCFAs), hippurate, indole derivatives, branched-chain amino acids (BCAAs), and bile acids (BAs) are among the key co-metabolites implicated in MASLD progression. In this review, we will unravel the relationship between the microbiota-related metabolites which have been associated with MASLD and that could play an important role for developing effective therapeutic interventions for MASLD and related metabolic disorders.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pathology, University of Valencia, 46010 Valencia, Spain.
- University Clinical Hospital of Valencia Research Foundation (INCLIVA), 46010 Valencia, Spain.
ORCID-Profile: Maria Martin-Grau, Daniel Monleón
Förderung
- University of Valencia
Zitieren
APA
Martin-Grau, M., & Monleón, D. (2024). The Role of Microbiota-Related Co-Metabolites in MASLD Progression: A Narrative Review. Current Issues in Molecular Biology, 46(7), 6377-6389. https://doi.org/10.3390/cimb46070381
Vancouver
Martin-Grau M, Monleón D. The Role of Microbiota-Related Co-Metabolites in MASLD Progression: A Narrative Review. Current Issues in Molecular Biology. 2024;46(7):6377-6389. doi:10.3390/cimb46070381
BibTeX
@article{MartinGrau2024,
author = {Martin-Grau, Maria and Monleón, Daniel},
title = {The Role of Microbiota-Related Co-Metabolites in MASLD Progression: A Narrative Review},
journal = {Current Issues in Molecular Biology},
year = {2024},
volume = {46},
number = {7},
pages = {6377--6389},
doi = {10.3390/cimb46070381}
}
EUVIMED